Testing effectiveness (Phase 2)Not Yet RecruitingNCT07825389What this trial is testingC-CAR168 in Participants With Progressive Multiple SclerosisWho this might be right forMultiple Sclerosis AbelZeta Inc. 119
Not applicableEnded earlyNCT06455475What this trial is testingDerm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment AloneWho this might be right forDiabetic Foot Ulcer Capsicure, LLC 120
Early research (Phase 1)Study completedNCT01346358What this trial is testingIMC-CS4 in Subjects With Advanced Solid TumorsWho this might be right forNeoplasms Eli Lilly and Company 52
Early research (Phase 1)Study completedNCT01340040What this trial is testingDose-escalation Study to Assess Safety, Tolerability and Pharmacokinetics of MEDI-573 in Japanese SubjectsWho this might be right forCancerAdvanced Solid Malignancies AstraZeneca 10
Not applicableStudy completedNCT00230243What this trial is testingHistorical Control Study of Refractory IFI or Patients Intolerant to Standard Antifungal Therapy in Patients With Invasive Fungal Infections (Study P02387)Who this might be right forInfection, Invasive Fungal Merck Sharp & Dohme LLC 330
Testing effectiveness (Phase 2)Study completedNCT01421186What this trial is testingA Phase 1/2a Study of Human Anti-CD 38 Antibody MOR03087 (MOR202) in Relapsed/Refractory Multiple MyelomaWho this might be right forMultiple Myeloma MorphoSys AG 91
Not applicableWithdrawnNCT02347462What this trial is testingBilevel Positive Airway Pressure (BiPAP) for the Treatment of Moderate to Severe Acute Asthma ExacerbationsWho this might be right forAsthmaStatus Asthmaticus University of British Columbia
Not applicableEnded earlyNCT00358098What this trial is testingStudy to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer AHS Cancer Control Alberta 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07077564What this trial is testingThe Efficacy of TROP2-ADC in Advanced Extrapulmonary High-Grade Neuroendocrine Neoplasms Failure of Standard TherapyWho this might be right forNeuroendocrine Neoplasms (Tumours) Second Affiliated Hospital, Zhejiang University, School of Medicine 35
Large-scale testing (Phase 3)Study completedNCT00588406What this trial is testingStudy of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.Who this might be right forAsthma Northwell Health 95
Early research (Phase 1)Study completedNCT01014936What this trial is testingFirst-in-Man, Dose-escalation Trial of C-met Kinase Inhibitor MSC2156119J in Subjects With Advanced Solid TumorsWho this might be right forPatients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available EMD Serono 149
Testing effectiveness (Phase 2)UnknownNCT00081549What this trial is testingAroplatin and Gemcitabine in Patients With Advanced Pancreatic Cancer Resistant to Standard TherapiesWho this might be right forPancreatic Neoplasms Aronex Pharmaceuticals 111
Testing effectiveness (Phase 2)Study completedNCT00416624What this trial is testingEpoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by ChemotherapyWho this might be right forAnemiaLeukemiaLymphoma+4 more Mayo Clinic 239
Testing effectiveness (Phase 2)Active Not RecruitingNCT05547061What this trial is testingA Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-NGUL / Lu-177-DGUL in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Refractory to Standard TherapyWho this might be right forProstate CancermCRPC Cellbion Co., Ltd. 91
Early research (Phase 1)Study completedNCT02043847What this trial is testingTMI With HD Mel in ASCT for R/R Multiple Myeloma (BMT-03)Who this might be right forMultiple Myeloma, RelapsedMultiple Myeloma, Refractory to Standard Treatment University of Illinois at Chicago 12
Large-scale testing (Phase 3)Ended earlyNCT00000730What this trial is testingComparison of Three Treatments for Pneumocystis Pneumonia in AIDS PatientsWho this might be right forPneumonia, Pneumocystis CariniiHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 240
Large-scale testing (Phase 3)Active Not RecruitingNCT05263934What this trial is testingEfficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)Who this might be right forEosinophilic Granulomatosis With Polyangiitis GlaxoSmithKline 163
Not applicableStudy completedNCT06592222What this trial is testingLearn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma as Compared With Standard of Care TherapiesWho this might be right forMultiple Myeloma Pfizer 4
Testing effectiveness (Phase 2)Study completedNCT02464228What this trial is testingInvestigation of Tipifarnib in Treatment of Subjects With Peripheral T-Cell Lymphoma (PTCL) That Have Not Responded to Standard TherapyWho this might be right forRelapsed or Refractory Peripheral T-Cell Lymphoma Kura Oncology, Inc. 65
Testing effectiveness (Phase 2)UnknownNCT05029102What this trial is testingTAS-102 and Anlotinib in ≥3 Lines mGCWho this might be right forGastric Cancer Zhejiang University 45